0001104659-23-083066.txt : 20230721 0001104659-23-083066.hdr.sgml : 20230721 20230721163015 ACCESSION NUMBER: 0001104659-23-083066 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230721 DATE AS OF CHANGE: 20230721 EFFECTIVENESS DATE: 20230721 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Petros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815903 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851410058 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-487617 FILM NUMBER: 231102831 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 973-242-0005 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 D 1 primary_doc.xml X0708 D LIVE 0001815903 Petros Pharmaceuticals, Inc. 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY NEW YORK 10036 973-242-0005 DELAWARE None None Corporation true 2020 Mitchell Arnold 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Executive Officer Vice President of Finance and Principal Accounting Officer Fady Boctor 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Executive Officer President and Chief Commercial Officer John D. Shulman 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Director Joshua N. Silverman 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Director Bruce T. Bernstein 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Director Gregory Bradley 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Director Wayne R. Walker 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Director Pharmaceuticals Decline to Disclose 06b false 2023-07-13 false true true true false 0 Katalyst Securities LLC 112494 None None 655 THIRD AVENUE, 18TH FLOOR NEW YORK NY NEW YORK 10017 CT CONNECTICUT FL FLORIDA NJ NEW JERSEY NY NEW YORK false 30000006 30000006 0 Includes aggregate exercise price of warrants of $2.25 (subject to price-based adjustment), that may be received upon exercise of the warrants false 15 1200000 0 Issuer issued to placement agent (and its designees) warrants to purchase up to 533,334 shares at an exercise price of $2.25 (subject to price-based adjustment) under Section 4(a)(2) 0 false Petros Pharmaceuticals, Inc. /s/ Fady Boctor Fady Boctor President and Chief Commercial Officer 2023-07-21